What is Invesco's redeemable NCI?

Invesco (IVZ) reported redeemable NCI of $325.2M in Q1 2026.

How has Invesco's redeemable NCI changed year-over-year?

Invesco's redeemable NCI decreased by 40.4% year-over-year, from $545.5M to $325.2M.

What is the long-term trend for Invesco's redeemable NCI?

Over 5 years (2020 to 2025), Invesco's redeemable NCI has grown at a -18.7% compound annual growth rate (CAGR), from $211.8M to $75.4M.

Invesco IVZ Redeemable NCI

Redeemable NCI at other companies

T Rowe Price GroupTROW

$940.2M-3.8%

SEI InvestmentsSEIC

$269.9M—

Jefferies Financial GroupJEF

$406K0.0%

Equitable HoldingsEQH

——

Other financials

Income statement

See full

Revenue$1.7B+14.1%

Operating income$333.2M+20.2%

Net income$219.1M+28.1%

EPS (diluted)$0.51+34.2%

Balance sheet

See full

Cash & equivalents$1.7B-8.9%

Total debt$2.0B+104%

Total equity$12.3B-16.6%

Total assets$26.8B-4.7%

Cash flow

See full

Operating cash flow$212.6M+351%

CapEx$14.2M-39.3%

Free cash flow$198.4M+284%

Valuation

See full

Market cap$12.47B+58.6%

Enterprise value$12.73B+87.5%

P/S1.9×+0.6×

Profitability

See full

Operating margin-9.7%-24.3pp

Net margin-3.4%-12.7pp

FCF margin26.5%+8.7pp

Returns & leverage

See full

Return on equity-1.7%-5.5pp

Debt / equity0.2×+0.1×

Where this comes from

Reported directly by Invesco in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests.

The official record: Invesco’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Invesco's redeemable nci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Invesco's redeemable NCI?: Invesco (IVZ) reported redeemable NCI of $325.2M in Q1 2026.
How has Invesco's redeemable NCI changed year-over-year?: Invesco's redeemable NCI decreased by 40.4% year-over-year, from $545.5M to $325.2M.
What is the long-term trend for Invesco's redeemable NCI?: Over 5 years (2020 to 2025), Invesco's redeemable NCI has grown at a -18.7% compound annual growth rate (CAGR), from $211.8M to $75.4M.